Hereditary Angioedema Drug From CSL Gains German Backing
Hereditary angioedema therapy by CSL Behring gains positive nod in Germany.
Read MorePosted by Shajini | Jun 27, 2025 | News, Regulatory
Hereditary angioedema therapy by CSL Behring gains positive nod in Germany.
Read MorePosted by Shajini | Jun 27, 2025 | FDA Updates, News, Regulatory |
FDA import ban issued on Olympus medical devices from Japan for quality violations.
Read MorePosted by Shajini | Jun 27, 2025 | Litigation, Law & Policy, Neurology, News, Pricing & Market Access
Medicare exoskeleton coverage approved for ReWalk Personal Exoskeleton, sets key precedent.
Read MorePosted by Shajini | Jun 27, 2025 | News, Pricing & Market Access
New partnership advances reimbursement strategy for private practices.
Read MorePosted by Shajini | Jun 27, 2025 | Dealstreet, Neurology, News |
Vor Bio, RemeGen sign Global License Agreement for RC98 development.
Read More